Genetalks - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $90,266.76 +4.05%
Ethereum $3,238.05 +2.62%
BNB $635.29 +4.72%
Optimism $1.70 +10.15%
Arbitrum $0.63 +8.00%
Solana $219.71 +6.70%
Polygon $0.38 +2.15%
Cosmos $5.24 +5.68%
Avalanche $34.14 +6.93%

Bitcoin $90,266.76 +4.05%
Ethereum $3,238.05 +2.62%
BNB $635.29 +4.72%
Optimism $1.70 +10.15%
Arbitrum $0.63 +8.00%
Solana $219.71 +6.70%
Polygon $0.38 +2.15%
Cosmos $5.24 +5.68%
Avalanche $34.14 +6.93%

Genetalks

company

Summary
Funding Rounds
Investors

About

Genetalks provides medical and health solutions using genetic technology.

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥250M
Industries: Biotechnology,Genetics,Health Care,Medical
Founded date: Jul 7, 2014
Number Of Employee: 11 - 50
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥250M

Genetalks has raised a total of ¥250M in funding over 2 rounds. Their latest funding was raised on Jul 7, 2017 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 7, 2017	Series A	¥250M	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

Genetalks is funded by 2 investors. Harvest Capital and Hiyield Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Harvest Capital	—	Series A
Hiyield Capital	—	Series A